Osaka, Osaka Prefecture, Japan Shionogi is the famous Corporate Investor, which was founded in 1878. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Osaka-shi.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Shionogi, startups are often financed by Sears Capital Management, Montreux Equity Partners, Mitsubishi International Corporation (MIC). The meaningful sponsors for the fund in investment in the same round are OrbiMed, Montreux Equity Partners, Domain Associates.
Among the most popular fund investment industries, there are Medical, Biotechnology. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Vast Therapeutics, Peninsula Pharmaceuticals. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2019. The higher amount of exits for fund were in 2005. The typical startup value when the investment from Shionogi is 10-50 millions dollars.
Related Funds
| Fund Name | Location |
| A Capital | Chaoyang, China, Liaoning |
| Agile Fund | Beijing, Beijing, China |
| Altabix | - |
| Altico Capital India Private Limited | Bombay Santa Cruz, India, Maharashtra |
| Beta Catalyst | Chiyoda, Japan |
| Electrolux | Stockholm, Stockholm County, Sweden |
| GATX Ventures | California, Lafayette, United States |
| Healson Technology | China, Chongqing, Chongqing Shi |
| Huntington Ventures | California, Irvine, United States |
| Ideon Financial Solutions | Community of Madrid, Madrid, Spain |
| iptiQ of America | - |
| J-Stream | Japan, Tokyo |
| Leapfunder | Amsterdam, Noord-Holland, The Netherlands |
| MINTH Group | Beilun, China, Zhejiang |
| Origin Merchant Partners | Canada, Ontario, Toronto |
| Paddock Capital | Alberta, Calgary, Canada |
| Qianyi Touzi | - |
| Tendence Capital | Beijing, Beijing, China |
| University of Manchester | England, Manchester, United Kingdom |
| Wacker Chemie | Bayern, Germany, München |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Avita | $12M | 23 Aug 2024 | Tokyo, Kantō, Japan | ||
| $15M | 15 Jan 2019 | Durham, North Carolina, United States | |||
Peninsula Pharmaceuticals | $57M | 16 Jan 2004 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Avita | $12M | 23 Aug 2024 | Tokyo, Kantō, Japan | ||
| $15M | 15 Jan 2019 | Durham, North Carolina, United States | |||
Peninsula Pharmaceuticals | $57M | 16 Jan 2004 | California, United States |
